- ISIN
- US53635D2027
- CUSIP
- 53635D202
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jul 26, 2018
Highlights
- Market Cap
- $7.48B
- Enterprise Value
- $7.37B
- EPS (TTM)
- $0.23
- PE Ratio
- 361.38
- Total Revenue (TTM)
- $288.07M
- Gross Profit (TTM)
- $275.77M
- EBITDA (TTM)
- $51.53M
- Year Range
- $17.82 - $91.10
- Target Price
- $60.00
- ROA (TTM)
- 5.55%
- ROE (TTM)
- 20.54%
- Avg. Volume (1M)
- 1M
- Avg. Volume Value (1M)
- $115.99M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
LQDA Performance Chart
Liquidia Corporation (LQDA) is up 143.9% since the beginning of the year. At $84 per share, LQDA is trading 7.7% below its 52-week high of $91. Investors who bought $1,000 worth of LQDA shares 5 years ago would now be looking at an investment worth $36,569.
Loading charts...
Compare this symbol against anything
Returns By Period
Liquidia Corporation (LQDA) has returned 143.87% so far this year and 375.74% over the past 12 months.
Liquidia Corporation
- 1D
- -3.10%
- 1M
- 6.56%
- 6M
- 98.42%
- YTD
- 143.87%
- 1Y
- 375.74%
- 3Y*
- 120.93%
- 5Y*
- 105.41%
- 10Y*
- —
- ALL TIME*
- 26.92%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
LQDA Monthly Returns History
Based on dividend-adjusted daily data since Jul 26, 2018, LQDA's average daily return is +0.24%, while the average monthly return is +4.61%. At this rate, an investment would double in approximately 1.3 years.
Historically, 57% of months were positive and 43% were negative. The best month was May 2020 with a return of +85.5%, while the worst month was Aug 2019 at -44.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.
On a daily basis, LQDA closed higher 50% of trading days. The best single day was Jul 19, 2022 with a return of +45.3%, while the worst single day was Aug 19, 2024 at -30.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 22.91% | -26.82% | 21.66% | 3.90% | 57.77% | 28.89% | 5.49% | 143.87% | |||||
| 2025 | 21.00% | 8.85% | -4.78% | -5.29% | 6.80% | -16.49% | 50.00% | 48.10% | -17.85% | 7.12% | 33.95% | 5.70% | 193.28% |
| 2024 | 6.23% | 10.80% | 4.17% | -12.88% | 0.16% | -6.76% | -0.58% | -20.28% | 5.15% | 8.50% | 6.45% | 1.82% | -2.24% |
| 2023 | 3.61% | 14.70% | -8.72% | -2.89% | 21.01% | -3.33% | -1.66% | -11.01% | -7.71% | 2.68% | 9.98% | 68.02% | 88.85% |
| 2022 | 16.22% | 14.31% | 10.97% | -24.23% | -25.37% | 7.39% | 12.50% | 17.64% | -5.72% | -10.11% | 2.66% | 26.89% | 30.80% |
| 2021 | -7.12% | 2.19% | -3.93% | 5.58% | 5.99% | -4.98% | -19.58% | 16.09% | 3.37% | 35.87% | 10.67% | 17.35% | 65.08% |
Benchmark Metrics
Liquidia Corporation has an annualized alpha of 58.58%, beta of 0.99, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since July 26, 2018.
- This stock captured 104.74% of S&P 500 Index gains but only 46.89% of its losses - a favorable profile for investors.
- R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 58.58%
- Beta
- 0.99
- R²
- 0.05
- Upside Capture
- 104.74%
- Downside Capture
- 46.89%
Return for Risk
Risk / Return Rank
LQDA ranks 98 for risk / return — above 98% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Liquidia Corporation (LQDA) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LQDA | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.89 | ||
| Sortino ratioReturn per unit of downside risk | +2.74 | ||
| Omega ratioGain probability vs. loss probability | 1.56 | 1.25 | +0.31 |
| Calmar ratioReturn relative to maximum drawdown | 9.89 | 2.00 | +7.89 |
| Martin ratioReturn relative to average drawdown | 25.71 | 8.49 | +17.22 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Liquidia Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Liquidia Corporation was 93.87%, occurring on Aug 4, 2021. Recovery took 1115 trading sessions.
The current Liquidia Corporation drawdown is 5.53%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-93.87%Aug 2021 | 2y 9mo | 4y 5mo | 7y 3moOct 2018 - Jan 2026 | — |
-35.66%Feb 2026 | 21d | 2mo 15d | 3mo 6dFeb 2026 - May 2026 | — |
-12.57%Jul 2026 | 3d | 9d | 12dJul 2026 - Jul 2026 | — |
-11.97%Jul 2018 | 5d | 9d | 14dJul 2018 - Aug 2018 | — |
-11.16%Jun 2026 | 4d | 2d | 6dMay 2026 - Jun 2026 | — |
Drawdown Indicators
| LQDA | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.87% | -56.78% | -37.09% |
Max Drawdown (1Y)Largest decline over 1 year | -35.66% | -9.10% | -26.56% |
Max Drawdown (3Y)Largest decline over 3 years | -46.80% | -18.90% | -27.90% |
Max Drawdown (5Y)Largest decline over 5 years | -55.36% | -25.43% | -29.93% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -5.53% | -1.58% | -3.95% |
Average DrawdownAverage peak-to-trough decline | -68.43% | -10.70% | -57.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.69% | 2.14% | +11.55% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Liquidia Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Liquidia Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for LQDA, comparing it with other companies in the Biotechnology industry. Currently, LQDA has a P/E ratio of 361.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for LQDA relative to other companies in the Biotechnology industry. Currently, LQDA has a P/S ratio of 28.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for LQDA in comparison with other companies in the Biotechnology industry. Currently, LQDA has a P/B value of 78.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with LQDA
Add Liquidia Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with LQDA